Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
Harrison, Stephen A., Neff, Guy, Guy, Cynthia D., Bashir, Mustafa R., Paredes, Angelo H., Frias, Juan P., Younes, Ziad, Trotter, James F., Gunn, Nadege T., Moussa, Sam E., Kohli, Anita, Nelson, KristiJournal:
Gastroenterology
DOI:
10.1053/j.gastro.2020.08.004
Date:
August, 2020
File:
PDF, 1.39 MB
2020